Ameriprise’s Columbia Research Enhanced International Equity ETF REFA Stock Holding History

Ameriprise’s Portfolio REFA Stock Details REFA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.81M	Buy	85,313 +35,263	+70%	+$761K	﹤0.01%	3006
2025 Q4	$1.03M	Buy	+50,050	New	+$1.02M	﹤0.01%	3316

Other funds holding REFA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise's REFA Position: Q1 2026 in Review

Ameriprise increased its Columbia Research Enhanced International Equity ETF (REFA) stake by 70% in Q1 2026, buying an estimated $761K and bringing the position to 85,313 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #3006.

Ameriprise first reported a position in REFA in Q4 2025 and has held it in 2 quarters since. 5 funds tracked by Wall St. Rank hold REFA as of Q1 2026.

Ameriprise held 85,313 shares of Columbia Research Enhanced International Equity ETF worth $1.81M as of Q1 2026.
Ameriprise bought 35,263 Columbia Research Enhanced International Equity ETF shares in Q1 2026, an estimated $761K.
Columbia Research Enhanced International Equity ETF made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3006 holding.
Ameriprise first reported a position in Columbia Research Enhanced International Equity ETF in Q4 2025 and has held it in 2 quarters since.
5 funds tracked by Wall St. Rank held Columbia Research Enhanced International Equity ETF as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.